The clinical effectiveness and cost effectiveness of rosiglitazone for type 2 diabetes mellitus: assessment report. NICE Technology Appraisal (TA9)
The clinical effectiveness and cost effectiveness of rosiglitazone for type 2 diabetes mellitus: assessment report. NICE Technology Appraisal (TA9)
National Institute for Clinical Excellence
Lord, J.
fd3b2bf0-9403-466a-8184-9303bdc80a9a
Paisley, S.
20701a35-5a37-4e78-b80e-9c280bd4e9f1
Taylor, R.
1abcd415-ae2c-4e95-a761-6948ce7f4d32
2000
Lord, J.
fd3b2bf0-9403-466a-8184-9303bdc80a9a
Paisley, S.
20701a35-5a37-4e78-b80e-9c280bd4e9f1
Taylor, R.
1abcd415-ae2c-4e95-a761-6948ce7f4d32
Lord, J., Paisley, S. and Taylor, R.
(2000)
The clinical effectiveness and cost effectiveness of rosiglitazone for type 2 diabetes mellitus: assessment report. NICE Technology Appraisal (TA9)
London, GB.
National Institute for Clinical Excellence
Record type:
Monograph
(Project Report)
This record has no associated files available for download.
More information
Published date: 2000
Additional Information:
ID: 46424
Organisations:
Primary Care & Population Sciences
Identifiers
Local EPrints ID: 382195
URI: http://eprints.soton.ac.uk/id/eprint/382195
PURE UUID: 1eb6ab77-7198-4950-9abd-9d2ff16449c4
Catalogue record
Date deposited: 09 Oct 2015 13:49
Last modified: 23 Jul 2022 02:11
Export record
Contributors
Author:
S. Paisley
Author:
R. Taylor
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics